Related Experiment Videos
[Historical perspective of hormone replacement therapy]
1Service d'endocrinologie et des maladies de la reproduction, hôpital Bicêtre, 94275 Le Kremlin-Bicêtre. philippe.chanson@bct.ap-hop-paris.fr
La Revue Du Praticien
|April 15, 2005
Summary
Hormone replacement therapy (HRT) was once thought to benefit postmenopausal women but is now known to increase risks, particularly cardiovascular issues. Current recommendations focus on symptom relief, emphasizing evidence over past beliefs.
Area of Science:
- Reproductive endocrinology and women's health.
- Cardiovascular disease prevention.
- Clinical trial evidence and medical beliefs.
Context:
- Menopause-related estrogen deficiency impacts women's health.
- Hormone replacement therapy (HRT) was widely used for menopausal symptoms and chronic conditions.
- Early beliefs favored HRT for cardiovascular benefits, supported by cohort studies.
Purpose:
- To re-evaluate the established understanding of hormone replacement therapy (HRT) in postmenopausal women.
- To assess the cardiovascular risks and benefits of HRT based on randomized controlled trials.
- To inform current medical recommendations regarding HRT use.
Summary:
- Randomized trials like HERS and WHI revealed that HRT increases, rather than prevents, cardiovascular risk.
- This evidence shifted the risk/benefit ratio unfavorably, leading to decreased HRT use.
- Current HRT indications prioritize managing menopausal symptoms, with ongoing research into administration routes and progestin effects.
Impact:
- Profoundly altered clinical practice and patient management regarding HRT.
- Highlighted the critical importance of scientific evidence over prevailing beliefs in medicine.
- Led to revised guidelines focusing on symptom management and cautious HRT prescription.